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Background: Multiply injured patients are at risk of complications including infections, acute 
and prolonged organ dysfunction. The immunologic response to injury has been shown to affect 
outcomes. Recent advances in computational capabilities have shown that early dynamic 
coordination of the immunologic response is associated with improved outcomes after trauma. 
We hypothesized that patients who were sensitive or tolerant of hemorrhage would demonstrate 
differences in dynamic immunologic orchestration within hours of injury. 
Methods: We identified two groups of multiply injured patients that demonstrated distinct 
clinical tolerance to hemorrhage (n = 10) or distinct clinical sensitivity to hemorrhage (n = 9) 
from a consecutive cohort of 100 multiply injured patients. Hemorrhage was quantified by 
integrating elevated shock index values for 24 hours after injury (Shock Volume). Clinical 
outcomes were quantified by average Marshall Organ Dysfunction Scores (MODS) from days 
two to five (aMODSD2-D5) after injury. Shock Sensitive (SS) patients had high cumulative organ 
dysfunction after lower magnitude hemorrhage. Shock Tolerant (ST) patients had low 
cumulative organ dysfunction after higher magnitude hemorrhage. Computational methods were 
used to analyze a panel of twenty immunologic mediators collected serially over the initial 72 
hours after injury. 
Results: Dynamic Network Analysis demonstrated the ST patients had increased orchestration 
of cytokines that are reparative and protective including interleukins 9, 17E/25, 21, 22, 23 and 33 
during the initial 0-8hr and 8-24hr intervals after injury. SS patients had delayed immunologic 
orchestration of a network of largely pro- and anti-inflammatory mediators. Elastic Net Linear 








Conclusions: Preliminary evidence from this study suggest that early immunologic orchestration 
discriminates between patients who are notably tolerant or sensitive to hemorrhage. Early 
orchestration of a group of reparative/protective mediators was amplified in Shock Tolerant 
patients.  
 
Study Type: Original Article Prospective Clinical Outcomes Study 
 
Level of Evidence: III 
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  Multiply injured patients (MIPs) are at risk of developing complications. Typically, 
complications are related to the magnitude of injury and hemorrhage. For example, in recent 
work the magnitude of cumulative hypoperfusion corresponded to organ dysfunction, duration of 
mechanical ventilation and nosocomial infections. [1] However, there are anecdotal examples of 
patients that recover uneventfully after major injury or conversely, are plagued with 
complications after less severe injury.  
  Outcomes after trauma and hemorrhagic shock (HS) are clearly affected by the immunologic 
response to injury. [2-6] The immunologic response is complex, with multidimensional temporal 
and spatial relationships among immune cells and the biochemical communication orchestrated 
by the cells primarily through various inflammatory mediators. The complexities of the response 
are highlighted by uniform failure in the clinical trauma arena to improve outcomes by 
mitigating individual immunologic mediators expressed after injury. [7] Recently, multiple 
studies have yielded novel insights into the trauma immunologic response by employing 
computational methods that can account for temporal and spatial networks of mediators. [2-6, 8-
10] Rather than focusing on isolated mediators -- typically cytokines and chemokines -- several
studies have shown that immunologic orchestration among mediators better corresponds to 
favorable vs. unfavorable outcomes. [8, 11, 12] Patients who demonstrate early immunologic 
coordination followed by subsequent dissipation of dynamic networks of mediators have more 
favorable outcomes. In contrast, patients with poor early network orchestration followed by 






immunologic network formation is affected by the magnitude of injury severity [4, 5, 8], but it is 
distinctly possible that tolerance to trauma is affected by individual capability to orchestrate a 
favorable coordinated immune response at the time of injury.  
  We hypothesized that differences in the composite immunologic response would stratify 
tolerance to trauma and hemorrhagic shock (HS). We explored this concept in a prospective 
cohort of MIPs. Specifically, we identified two demographically similar groups of patients from 
a prospective cohort of 100 MIPs, that exhibited significant clinical tolerance or sensitivity to 
hemorrhage. Shock Tolerant (ST) patients had uncomplicated outcomes despite having increased 
cumulative hypoperfusion in the first 24 hr after injury. In contrast, Shock Sensitive (SS) patients 
had poor outcomes despite having significantly less cumulative hypoperfusion during the same 
period. We hypothesized that there would be differences in individual circulating concentrations 
of immunologic mediators as well as distinct feature differences in dynamic networks of 
mediators between ST and SS cohorts. Our results identified two consistent clusters of 
immunologic mediators occurred in trauma patients. Furthermore, our results showed that SS 
patients had delayed overall mediator orchestration, delayed formation of a distinct mediator 
cluster associated with tissue repair and protection, and time-dependent increases in mediator 
network connectivity in a second cluster of inflammatory mediators. In contrast, ST patients had 
robust early mediator orchestration, specific orchestration primarily within the tissue 
protective/reparative cluster, and dissolution of mediator connectivity over time. 
Methods 






prospectively enrolled 100 blunt trauma MIPs (Figure 1). Patients were 18 to 55 years old and 
met the following criteria: 1) presented as a full trauma activation defined by the General 
Surgical trauma team with the attending surgeon present at the initial resuscitation; 2) were 
admitted to surgical ICU or proceeded directly to surgery and were then admitted to surgical 
ICU. We excluded patients with non-survivable or severe traumatic brain injuries (TBI; Glasgow 
Coma Score of < 7 at presentation with no improvement after 48 hours after injury).  
 
  Fifty-one of the original 100 patients had TBI of which 15 were excluded when their GCS 
remained < 7 after 48 hr. Three patients with spinal cord injuries were also excluded. One 
additional patient sustained an iatrogenic air embolus with cardiac arrest and was excluded. This 
yielded the final study cohort of 81 patients (Figure 1). 
 
Shock Tolerance and Shock Sensitivity. The purpose of this study was to compare immunologic 
profiles in patients that demonstrated wide discrepancy in tolerating hemorrhage. We compared 
the magnitude of hemorrhage to the magnitude of organ dysfunction to stratify individual 
tolerance/sensitivity to hemorrhage. Cumulative hypoperfusion during the first 24 hr after injury 
was used to define the magnitude of hemorrhage. [1, 13] Previously, we demonstrated that 
cumulative hypoperfusion, measured by temporal integration of abnormally elevated shock index 
values over the first 24 hr after injury corresponded closely with transfusion requirements and 
organ dysfunction (Figure 2). [1, 13] The cumulative hypoperfusion index, 24hr Shock Volume 
(24hr SHVL), demonstrated significantly greater correspondence with outcomes including organ 
dysfunction compared to Injury Severity Score (ISS) and Base Deficit (BD). Notably, organ 
dysfunction, nosocomial infections (NI) and transfusions increased abruptly in patients with 24hr 






SHVL > to a threshold of 100 units. The magnitude of organ dysfunction was calculated by 
using serial Marshall Organ Dysfunction Scores (MODS). Previously we demonstrated that 
MODS averaged from days two to five after injury, aMODSD2-D5, identified patients at risk for 
prolonged ICU length of stay (ICUDays), prolonged mechanical ventilation (MVDays) and NI. [1, 
11, 12] In this work, there was a stark threshold of aMODSD2-D5 > 4 that predicted poor 
outcomes.  
  From the cohort of 81 patients, we defined ST patients as those with aMODSD2-D5 < 4 and 24hr 
SHVL > 100 (Figure 1, n = 10; Figure 2 red dashed box). In contrast, SS patients were defined 
by an aMODSD2-D5 > 4 and 24hr SHVL < 100 (Figure 1, n = 9; Figure 2 black dashed box). 
Initially, injury severity and demographics of the ST and SS groups were determined including 
ISS, age, gender, and Glasgow Coma Score (GCS). Subsequently, both groups were closely 
studied to identify more granular discrepancies in injury characteristics that may have accounted 
for differences in outcomes. Specifically, medical records were scrutinized to evaluate all 
preexisting comorbidities, trauma related diagnoses, the magnitude, type and resolution of TBI, 
the magnitude of initial hemorrhage, metabolic response to hemorrhage, transfusions, surgical 
interventions and mechanism of injury.  
Cytokine and Chemokine Measurements. Serial panels of 20 cytokines, chemokines and high 
mobility group box one (HMGB1) were measured using a multiplex platform (Luminex
TM
;
Luminex Corporation, Austin, TX). The following inflammatory mediators were measured: 
Interleukin (IL)-1β, IL-1 receptor antagonist (IL-1RA), soluble IL-2 receptor-α (sIL-2Rα), IL-4, 
IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-17A, IL-17E/IL-25, IL-21, IL-22, IL-23, IL-33, interferon 






gamma-induced protein 10 (IP-10), monokine induced by interferon gamma (MIG), monocyte 
chemoattractant protein-1 (MCP-1), and HMGB1. Mean values of individual mediators were 
calculated. Plasma was collected at the time of admission (0 hr), and subsequently at 8, 24, 48 
and 72 hr after admission. Blood samples were all processed within two hours of collection. 
Samples were centrifuged at room temperature at 1500 rpm for 10 minutes. 1.0 ml of plasma was 
aliquoted into separate cryovial tubes and immediately frozen at -80 degrees Celsius. 
 
Computational Modeling and Analyses: Two distinct analyses were conducted to evaluate 
immunologic orchestration and patterns of mediators. Time-dependent changes in mediator 
connectivity were measured using Dynamic Network Analysis (DyNA). [4, 14]. Discriminant 
Analysis [15-18] paired with Elastic Net Linear Regression (ENLR) [19] was used to identify 
cytokine networks that discriminated the ST and SS groups and the time windows in which the 
distinguishing networks were most evident. 
 
Dynamic Network Analysis: These analyses explored temporal changes in network connectivity 
and complexity of the post-traumatic inflammatory response between the ST and SS groups. We 
have used DyNA in multiple studies which specifically detail the methods. [2, 9, 14] 
Inflammatory mediator networks were created in the sampling intervals (0-8 hr; 8–24 hr; 24–48 
hr and 48–72 hr) using MATLAB
®
 (The MathWorks, Inc., Natick, MA) as we have done 
previously [2, 9, 14, 20]. Connections in the network were created if the correlation coefficient 
between two nodes (inflammatory mediators) was greater or equal to a threshold of 0.85. For the 
network density calculation, in order to account for network sizes (number of significantly 
altered nodes) in the adjacent time periods detailed above, we utilized the following formula: 







   Total number of edges * Number of total nodes 
   Maximum possible edges among total nodes 
 
Discriminant Analysis with Elastic Net Linear Regression. We performed a set of discriminant 
analyses with several widely used statistical and machine learning methods to examine the 
predictive power of the biomarkers in differentiating the ST and SS groups. Initially, the 
biomarkers were analyzed based on 1) individual cytokines concentrations at each discreet time 
point (0, 8, 24, 48 and 72 hr); and 2) differences in each cytokine between adjacent time points 
(0–8 hr; 8–24 hr; 24–48 hr and 48–72 hr). Multivariate discriminant analyses of the above 
biomarker measures were examined between the SS and ST cohorts. Pattern classification was 
performed with four widely used machine learning methods including 1) Support Vector 
Machine learning using either Linear (Linear SVM) or Radial Basis Function (RBF SVM) as its 
kernel [15, 16]; 2) Decision Tree analyses [17]; and 3) Random Forest Modeling [18]. 
Classification performance was evaluated by leave-one-out cross-validation accuracy. Briefly, 
one observation was omitted and the classifier was learned from the remaining n-1 observations. 
The classifier was then applied to the hold out observation and the accuracy was recorded. This 
was repeated for all observations, and the average of all the recorded accuracies was used to 
evaluate the classification performance. Based on these analyses, we determined that the 0-8 hr 
difference values between cytokines yielded the best cross-validation accuracy. Accordingly, we 
applied ENLR analyses [19] to 0-8 hr cytokine difference values to identify networks of 
biomarkers that best discriminated between ST and SS cohorts.  
 






  ENLR is a sparse learning model including both the least absolute shrinkage and selection 
operator (LASSO) and ridge regularizations. By adjusting a model parameter balancing the 
LASSO and ridge effects, we identified the 11 most predictive cytokines with varying sparsity 
levels ranging from one relevant cytokine through all eleven cytokines respectively. To evaluate 
the power of the selected cytokines, we applied the above four classification methods (i.e., 
Linear SVM, RBF SVM, Decision Tree, and Random Forest) using only the eleven identified 
cytokines as predictors and estimated the leave-one-out cross-validation accuracy. These focused 
analyses were conducted only on the eleven identified cytokines and we compared differences 
between SS vs ST patients. 
  All the above machine learning analyses were implemented using Python with its libraries 
including NumPy, Pandas and Scikit-learn, and were performed on a desktop running Ubuntu 
18.04 with Python3.6 installed. 
Statistical Analyses for Clinical Data. Continuous clinical and demographical data were 
compared with paired Student’s t-tests or Analysis of Variance (ANOVA) when appropriate. 
Categorical data were compared by Chi-Squared analyses. 
Results 
Organ dysfunction correlated with cumulative hypoperfusion. ST and SS groups were identified 
as outliers from regression analyses. Significant correspondence (R
2
 = 0.49) was demonstrated
between 24hr SHVL and aMODSD2-D5 from the entire cohort of 81 patients (Figure 2). Two 
outlier groups were observed including a group of ten ST patients with 24hr SHVL > 100 and 






aMODSD2-D5 < 4 (red dashed box, Figure 2), and nine SS patients with 24hr SHVL < 100 and 
aMODSD2-D5 > 4 (black dashed box, Figure 2).  
 
Demographics, Injury Severity, Injury Distribution and Surgical Interventions were homogenous 
between SS and ST patients. There were no differences in age or gender between SS patients and 
ST patients (Table 1). The mean ISS for SS and ST patients was 32.0 (range 9 to 50; s.d. = 13.2) 
and 29.6 (range 21 to 48; s.d. = 8.6; p = 0.65) and the majority of patients in both groups were 
injured in motor vehicle collisions (Table 1). Demographics, injury severity and mechanism of 
injury from both SS and ST patients reflected the overall cohort of 81 patients.  
 
  Injury distribution and surgical interventions were similar between the two experimental groups 
(Table 1). SS patients had more spine injuries in contrast to ST patients who had more abdominal 
and extremity injuries, however none of the differences were significant. Surgical interventions 
were similar between groups and reflected differences in spine and abdominal injuries. Granular 
details demonstrated no substantial differences in the initial magnitude and resolution of TBI 
between ST and SS patients (Table 1).  
 
Clinical Outcomes reflect higher organ dysfunction and resource utilization in SS patients 
compared to ST patients (Supplemental Table 1, http://links.lww.com/TA/B832). Compared to ST 
patients, SS patients had a 5-fold increase in the MVDays (p < 0.01) and a 3-fold increase in 
ICUDays (p < 0.001). Likewise, SS patients had a greater incidence of NI (p = 0.011) and a 2.3-
fold increase in aMODSD2-D5 (p < 0.001) compared to ST patients. Individual organ dysfunction 
trajectories confirmed that ST patients (red lines Figure 3) resolved organ dysfunction primarily 






between hospital days 2 and 3, compared to SS patients which had little resolution of organ 
dysfunction from the time of injury to day five (black lines Figure 3). 
 
Hemorrhage based outcomes demonstrated trends toward more bleeding in ST patients but no 
differences in anaerobic metabolism (Supplemental Table 2, http://links.lww.com/TA/B833). 
Bleeding indices, serum measurements of anaerobic metabolism and transfusion requirements in 
the first 24 hr demonstrated that ST patients had greater 24hr SHVL (by definition of the study 
design) which is reflected in significantly higher HR (p < 0.01) and a trend toward greater Shock 
Index (p = 0.11) at the time of injury compared to SS patients. However, there were no 
differences in anaerobic indices (BD and pH) during the initial 0–24 hr after injury between the 
groups. Initial Hgb was 0.8 g/dl lower in ST patients compared to SS patients but the difference 
was not significant. Four of ten ST patients had a critical transfusion requirements [21] (three or 
more units of PRBCs transfused within a 60 minute period) compared to two of nine patients in 
the SS group. Likewise, three of ten of the ST patients had a massive transfusion (10 or more 
units of PRBCs in a 24 hr period) compared to one of nine SS patients. With the small numbers 
of patients, differences in the incidence of Massive Transfusion and Critical Administration 
Transfusions were not significant. Likewise, there were no statistical differences in mean units of 
packed red blood cell (PRBCs), platelet, and plasma (FFP) transfusions between the groups. 
However, mean 0-24 hr transfusion values in SS patients were largely influenced by a single 
patient that received a massive transfusion. There were minimal transfusions in either group after 
the first 24 hr (Supplemental Table 2, http://links.lww.com/TA/B833). In summary, ST patients 
had greater cumulative hypoperfusion and tachycardia, but no evidence of increased anaerobic 
metabolism compared to SS patients.  






There were minimal differences in individual mediator concentrations between the SS and ST 
patients at any time point. Differences in individual mediators between the groups were scattered 
(Supplemental Figure 1, http://links.lww.com/TA/B831) but the only individual mediator that 
was significantly different between the two groups was HMGB1 which was higher in SS 
patients. None of the cytokines or chemokines were different between the two groups. 
Two distinct clusters of mediators were observed in both experimental groups. DyNA quantifies 
coordination between individual mediators within a time interval. Two clusters of mediators 
were consistently observed in DyNA in both groups (Figure 4; Supplemental Figure 2, 
http://links.lww.com/TA/B830). The first cluster included eleven cytokines, primarily associated 
with pro and anti-inflammatory functions [22, 23], including IL-1β, IL-17A, IL-1RA, IL-4, IL-5, 
IL-6, IL-7, IL-8, IL-10, IP-10 and MCP-1 (Cluster One; delineated in the black dashed boxes in 
Figure 4). The second cluster had six cytokines including IL-9, IL-21, IL-22, IL-23, IL-33 and 
IL-17E/25 (Cluster Two; red dashed boxes Figures 4) that have been associated with reparative 
functions and boundary organ protection. [24-26]  
SS patients had reduced overall early dynamic mediator orchestration and delayed coordination 
of Cluster Two compared to ST patients. In the first 0-8 hr interval, there were only five overall 
mediator connections in SS patients compared to eleven connections in ST patients (Figure 4). 
Overall DyNA connections increased to fourteen connections in the 8-24 hr interval (Figure 4) in 
SS patients which primarily reflected robust development of Cluster One (Figure 4 black dashed 
box). Conversely, in the 0-8 hr and 8-24 hr intervals, SS patients had only three DyNA 






connections between mediators in Cluster Two (Figure 4 red dashed boxes). In contrast, ST 
patients had early and robust dynamic orchestration of Cluster Two (Figure 4 red dashed boxes) 
forming seven connections in the 0-8 hr interval which expanded to twelve connections in the 8-
24 hr interval. In the 8-24 hr interval, IL-21 and IL-9 were both connected to five other 
mediators and IL-17E/25 and IL-33 formed four connections. Interestingly, in the 48-72 hr 
interval, there was complete dissolution of all connectivity in ST patients.  
 
SS patients had greater connectivity of Cluster One compared to ST patients. SS patients 
developed a highly orchestrated network involving Cluster One (Figure 4 black dashed box) in 
the 8-24 hr interval forming eleven overall connections. MCP-1 was connected to five other 
mediators. IL-1β, IL-6 and IL-10 were connected to four other mediators. In contrast, ST patients 
formed only six connections in Cluster One in the 8-24 hr interval and MCP-1 formed no 
connections (Figure 4 black dashed box).  
 
Discriminant Analyses and Elastic Net Linear Regression demonstrated that mediator 
differences between 0 hr and 8 hr were most discriminating between SS and ST patients. 
Discriminant analyses demonstrated that both Random Forest Modeling and Decision Tree 
Analysis were superior in identifying mediators that best distinguished ST from SS patients 
(Table 2). In addition, the highest discriminant values were consistently measured by modeling 
the 0–8 hr mediator difference values.  
 
  ENLR (Table 2) identified a hierarchical order of mediators that best distinguished ST and SS 
patients. MIG was the single most distinguishing mediator between SS and ST patients. Immune 






response differences between SS and ST patients were statistically distinguished by including 0–
8 hr differences in five mediators (in descending order of influence) including MIG, sIL-2RA, 
IL-23, MCP-1 and IL-1RA (R
2
 = 0.191; p = 0.021). However, this initial model accounted for
only 19% of the variance between the two groups. Adding 0–8 hr changes in IL-6, IP-10 and IL-
22 to the model nearly doubled the discriminating power between ST and SS patients with an R
2
value of 0.368. Finally, incremental increases in regression correspondence were quantified with 
the addition of IL-10 and IL-17E/IL-25.  
Discussion 
  The data from this experiment demonstrated differences in the immunologic response in 
patients identified as ST compared to patients identified as SS. We used computational 
approaches to account for the complexity of the immunologic response after injury. The most 
distinguishing features of the immunologic response between the two groups demonstrated that 
SS patients had overall reduced dynamic immunologic orchestration in the initial 0-8 hr interval, 
ST patients had greater immunologic orchestration in the first 24 hr after injury involving a 
distinct cluster of protective/reparative cytokines, SS patients had greater orchestration of a 
second distinct cluster of pro/anti-inflammatory cytokines, and in the latest 48–72hr interval ST 
patients had complete dissipation of all immunologic orchestration. Additionally, the single most 
distinguishing mediator between SS and ST groups identified from ENLR analyses, MIG, did 
not fit into either Cluster but formed a single connection with Cluster One in SS patients (Figure 
4). All observations need to be appropriately tempered by the small number of patients and the 
pathomechanistic significance of any of the observations is unknown. 






  Cluster One contains cytokines that have been associated with pro-inflammatory (IL-1β, IL-5, 
IL-6, IL-8, IP-10 and MCP-1) and anti-inflammatory (IL-1RA, IL-4, IL-10) functions. [22, 23] 
Cluster Two is comprised of cytokines that have substantial tissue protective/reparative effects. 
[24-26] Cluster Two cytokines are particularly protective of barrier organs including the skin, 
lung and gut all of which have been shown to be significantly compromised by injury. [25, 26] 
Interestingly, concentrations of IL-17E/25, IL-21, IL-23 and IL-33 were higher in survivors of 
blunt trauma at the time of admission compared to non-survivors. Furthermore, prehospital 
administration of plasma led to early increases in IL-17E/25, IL-21, IL-23 and IL-33 and 
increased survival compared to untreated patients. [27] In another retrospective report, IL-33 was 
elevated in blunt trauma survivors compared to a propensity matched group of non-survivors. 
[28]  
 
  Researchers have established that the immunologic response to injury plays a major and 
potentially dominant role in acute outcomes. [2, 4-6, 9, 11, 22, 23] Likewise, it is increasingly 
recognized that immunologic dysfunction affects longer-term outcomes after injury. [29, 30] 
Numerous studies have quantified association between immunologic mediators and outcomes, 
[31-35] however causation models linking individual mediator changes with postinjury 
phenotypes are notably absent. Accordingly, researchers are increasingly leveraging 
computational methods to understand how injury incites and propagates the immunologic 
response and how the response affects outcomes. [2, 4, 9, 14, 36, 37] For example, Abboud and 
colleagues demonstrated distinct immunologic feature differences, using DyNA, in blunt trauma 
survivors and non-survivors in closely matched cohorts. Survivors had early orchestration of 
predominantly lymphoid-based cytokines. Non-survivors had greater innate immunity-based 






cytokine networks that were initially delayed and then expanded in complexity over a 72-hour 
time frame. [2] In another study, patients with poor outcomes after subarachnoid hemorrhage had 
reduced initial cytokine orchestration with delayed progressive orchestration of cytokine 
networks that included MCP-1, IL-6 and IL-1RA (Cluster One cytokines). Conversely, in 
patients with good outcomes, network orchestration was early and IL-9 (Cluster Two cytokine) 
played a central role in mediator networks in survivors. [36] In summary, computational 
capabilities in trauma-based immunologic studies have uncovered consistent themes that 1) 
increasing injury severity uncouples early immunologic coordination; 2) early immunologic 
orchestration is associated with improved outcomes; and 3) patients with reduced initial 
immunologic orchestration followed by delayed expansion of immunologic network connectivity 
are at risk for poor outcomes. Methodologic advancements will be necessary to develop 
immunologic assay platforms and computational methods that can quantify individual 
immunologic networks at the time of injury to inform clinical decisions and interventions.  
 
  Our data are preliminary, and the experimental groups are small which could clearly affect the 
results. Accordingly, clinical extrapolation of these results is not possible. For example, 
transfusions in a single patient in the SS group more than doubled the mean values of transfused 
units of PRBCs, platelets and FFP within the SS group. Likewise, while there were more spine 
injuries in SS patients and more abdominal injuries in ST patients (Table 1), with the small group 
numbers the differences were not significant. It is possible that these differences may have 
affected the results. However, three of the four SS patients who had spine surgery did so within 
36 hours of injury and there were no additional transfusions associated with these three surgeries. 
Our findings will need to be validated in an expanded prospective trial. Our definition of ST and 






SS is admittedly arbitrary. However, in our foundational studies [1, 13] cumulative 
hypoperfusion was more accurate than ISS and BD in predicting outcomes. Other components 
specific to the injury and specific to the patient may better account for the clinical differences 
between the ST and SS cohorts. Transfusions were reported only for the initial 24hr in these 
groups. However, there were minimal transfusions in either group after the first 24hr 
(Supplemental Table 2, http://links.lww.com/TA/B833). We scrutinized injury-associated and 
demographic variables to identify alternative explanations for the clinical disparities between the 
two groups and found no meaningful differences (Table 1). Collectively, it is unlikely that 
clinical differences were attributable to demographics, injury magnitude and distribution, or 
interventions. Our analyses are singularly focused on the immunologic response to injury. We 
utilized two different computational methods to provide an in-depth exploration of the 
immunologic response at distinct cross-sections in the injury time frame and dynamically during 
progression of injury. However, it is possible that other global response mechanisms to injury 
such as metabolic response were more critical determinants of clinical outcomes.  
 
  In summary, from a larger cohort of MIPs, two selected sub-cohorts that had ST and SS clinical 
trajectories demonstrated fundamentally different computational immunologic responses. 
Increased early orchestration in cytokine networks corresponded to improved outcomes. In 
particular, early dynamic orchestration of a reparative/protective cluster of cytokines was 
increased in ST compared to SS patients. Larger populations of patients need to be interrogated 
to explore this model.  
 
  






Authorship: T.O.M., G.E.G., T.R.B. and Y.V. participated in study design, data collection and 
analysis, statistical analysis and manuscript preparation. R.Z., L.S., Q.S. and R.A.N participated 
in data collection and analysis, and manuscript preparation. 
Conflict of Interest: None of the authors have any conflict of interest pertaining to this work. 
Funding Sources. This work was supported by funding received from the Department of 
Defense Combat Casualty Care Research Program (Joint Program Committee-6) and the Major 
Extremity Trauma and Rehabilitation Consortium (METRC) funded through the Department of 
Defense Peer Reviewed Orthopaedic Research Program. 







1. McKinley TO, McCarroll T, Metzger C, Zarzaur BL, Savage SA, Bell TM, Gaski GE. 
Shock volume: Patient-specific cumulative hypoperfusion predicts organ dysfunction in a 
prospective cohort of multiply injured patients. J Trauma Acute Care Surg. 2018;85(1S 
Suppl 2):S84-S91. 
2. Abboud A, Namas RA, Ramadan M, Mi Q, Almahmoud K, Abdul-Malak O, Azhar N, 
Zaaqoq A, Namas R, Barclay DA, et al. Computational Analysis Supports an Early, Type 17 
Cell-Associated Divergence of Blunt Trauma Survival and Mortality. Crit Care Med. 
2016;44(11):e1074-e81. 
3. Abdul-Malak O, Vodovotz Y, Zaaqoq A, Guardado J, Almahmoud K, Yin J, Zuckerbraun 
B, Peitzman AB, Sperry J, Billiar TR, et al. Elevated Admission Base Deficit Is Associated 
with a Complex Dynamic Network of Systemic Inflammation Which Drives Clinical 
Trajectories in Blunt Trauma Patients. Mediators Inflamm. 2016;2016:7950374. 
4. Almahmoud K, Namas RA, Abdul-Malak O, Zaaqoq AM, Zamora R, Zuckerbraun BS, 
Sperry J, Peitzman AB, Billiar TR, Vodovotz Y. Impact of Injury Severity on Dynamic 
Inflammation Networks Following Blunt Trauma. Shock. 2015;44(2):101-9. 
5. Almahmoud K, Namas RA, Zaaqoq AM, Abdul-Malak O, Namas R, Zamora R, Sperry J, 
Billiar TR, Vodovotz Y. Prehospital Hypotension Is Associated With Altered Inflammation 
Dynamics and Worse Outcomes Following Blunt Trauma in Humans. Crit Care Med. 
2015;43(7):1395-404. 
6. Namas RA, Almahmoud K, Mi Q, Ghuma A, Namas R, Zaaqoq A, Zhu X, Abdul-Malak O, 
Sperry J, Zamora R, et al. Individual-specific principal component analysis of circulating 
inflammatory mediators predicts early organ dysfunction in trauma patients. J Crit Care. 







7. Spruijt NE, Visser T, Leenen LP. A systematic review of randomized controlled trials
exploring the effect of immunomodulative interventions on infection, organ failure, and
mortality in trauma patients. Crit Care. 2010;14(4):R150.
8. Almahmoud K, Abboud A, Namas RA, Zamora R, Sperry J, Peitzman AB, Truitt MS, Gaski
GE, McKinley TO, Billiar TR, et al. Computational evidence for an early, amplified
systemic inflammation program in polytrauma patients with severe extremity injuries. PloS
one. 2019;14(6):e0217577.
9. Namas RA, Vodovotz Y, Almahmoud K, Abdul-Malak O, Zaaqoq A, Namas R, Mi Q,
Barclay D, Zuckerbraun B, Peitzman AB, et al. Temporal Patterns of Circulating
Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection
Following Blunt Trauma in Humans. Ann Surg. 2016;263(1):191-8.
10. Schimunek L, Namas RA, Yin J, Liu D, Barclay D, El-Dehaibi F, Abboud A, Lindberg H,
Zamora R, Billiar TR, et al. An Enrichment Strategy Yields Seven Novel Single Nucleotide
Polymorphisms Associated With Mortality and Altered Th17 Responses Following Blunt
Trauma. Shock. 2018;49(3):259-68.
11. Gaski GE, Metzger C, McCarroll T, Wessel R, Adler J, Cutshall A, Brown K, Vodovotz Y,
Billiar TR, McKinley TO. Early Immunologic Response in Multiply Injured Patients With
Orthopaedic Injuries Is Associated With Organ Dysfunction. J Orthop Trauma.
2019;33(5):220-8.
12. Lamparello AJ, Namas RA, Constantine G, McKinley TO, Elster E, Vodovotz Y, Billiar
TR. A conceptual time window-based model for the early stratification of trauma patients. J
Intern Med. 2019;286(1):2-15.






13. McKinley TO, McCarroll T, Gaski GE, Frantz TL, Zarzaur BL, Terry C, Steenburg SD. 
Shock Volume: A Patient-Specific Index That Predicts Transfusion Requirements and 
Organ Dysfunction in Multiply Injured Patients. Shock. 2016;45(2):126-32. 
14. Mi Q, Constantine G, Ziraldo C, Solovyev A, Torres A, Namas R, Bentley T, Billiar TR, 
Zamora R, Puyana JC, et al. A dynamic view of trauma/hemorrhage-induced inflammation 
in mice: principal drivers and networks. PloS one. 2011;6(5):e19424. 
15. Cortes C, Vapnik V. Support Vector Networks. Machine Learning. 1995;20(3):273 - 97. 
16. Hocking RR. A Biometrics Invited Paper. The Analysis and Selection of Variables in Linear 
Regression. Biometrics. 1976;32(1):1-49. 
17. Quinlan JR. Induction of decision trees. Machine Learning. 1986;1(1):81-106. 
18. Tin Kam H. The random subspace method for constructing decision forests. 
IEEE Trans Pattern Anal Mach Intell. 1998;20(8):832-44. 
19. Zou H, Hastie T. Regularization and Variable Selection via the Elastic Net. J R Stat Soc 
Series B Stat Methodol. 2005;67(2):301-20. 
20. Ziraldo C, Vodovotz Y, Namas RA, Almahmoud K, Tapias V, Mi Q, Barclay D, Jefferson 
BS, Chen G, Billiar TR, et al. Central role for MCP-1/CCL2 in injury-induced inflammation 
revealed by in vitro, in silico, and clinical studies. PLoS One. 2013;8(12):e79804. 
21. Savage SA, Sumislawski JJ, Zarzaur BL, Dutton WP, Croce MA, Fabian TC. The new 
metric to define large-volume hemorrhage: results of a prospective study of the critical 
administration threshold. J Trauma Acute Care Surg. 2015;78(2):224-9; discussion 9-30. 
22. Huber-Lang M, Lambris JD, Ward PA. Innate immune responses to trauma. Nat Immunol. 
2018;19(4):327-41. 
23. Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, Kovacs EJ, Koenderman L, Kubes P, 






Lilford RJ. The systemic immune response to trauma: an overview of pathophysiology and 
treatment. Lancet. 2014;384(9952):1455-65. 
24. Anthony RM, Rutitzky LI, Urban JF, Jr., Stadecker MJ, Gause WC. Protective immune
mechanisms in helminth infection. Nat Rev Immunol. 2007;7(12):975-87.
25. Eyerich K, Dimartino V, Cavani A. IL-17 and IL-22 in immunity: Driving protection and
pathology. Eur J Immunol. 2017;47(4):607-14.
26. Robinson KM, Ramanan K, Clay ME, McHugh KJ, Rich HE, Alcorn JF. Novel protective
mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial
superinfection. Mucosal Immunol. 2018;11(1):199-208.
27. Gruen DS, Brown JB, Guyette FX, Vodovotz Y, Johansson PI, Stensballe J, Barclay DA,
Yin J, Daley BJ, Miller RS, et al. Prehospital plasma is associated with distinct biomarker
expression following injury. JCI Insight. 2020;5(8).
28. Billiar IM, Guardado J, Abdul-Malak O, Vodovotz Y, Billiar TR, Namas RA. Elevations in
Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical
Outcomes After Blunt Trauma. J Surg Res. 2019;244:23-33.
29. Horiguchi H, Loftus TJ, Hawkins RB, Raymond SL, Stortz JA, Hollen MK, Weiss BP,
Miller ES, Bihorac A, Larson SD, et al. Innate Immunity in the Persistent Inflammation,
Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy. Front
Immunol. 2018;9:595.
30. Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, Ungaro R, Davis R, Cuenca AG, Gentile LF,
Nacionales DC, Cuenca AL, Bihorac A, et al. Persistent inflammation, immunosuppression,
and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg.
2014;76(1):21-9; discussion 9-30.






31. Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Bruckner UB. Is interleukin 6 an 
early marker of injury severity following major trauma in humans? Arch Surg. 
2000;135(3):291-5. 
32. Gouel-Cheron A, Allaouchiche B, Guignant C, Davin F, Floccard B, Monneret G, AzuRea 
G. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful 
association to predict the development of sepsis after major trauma. PloS one. 
2012;7(3):e33095. 
33. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with 
the development of sepsis in trauma patients. J Trauma. 1996;40(4):613-6; discussion 6-7. 
34. Svoboda P, Kantorova I, Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor 
necrosis factor alpha in multiple trauma patients. J Trauma. 1994;36(3):336-40. 
35. Taniguchi M, Nakada TA, Shinozaki K, Mizushima Y, Matsuoka T. Association between 
increased blood interleukin-6 levels on emergency department arrival and prolonged length 
of intensive care unit stay for blunt trauma. World J Emerg Surg. 2016;11:6. 
36. Ahn SH, Savarraj JPJ, Parsha K, Hergenroeder GW, Chang TR, Kim DH, Kitagawa RS, 
Blackburn SL, Choi HA. Inflammation in delayed ischemia and functional outcomes after 
subarachnoid hemorrhage. J Neuroinflammation. 2019;16(1):213. 
37. Lamparello AJ, Namas RA, Abdul-Malak O, Vodovotz Y, Billiar TR. Young and Aged 
Blunt Trauma Patients Display Major Differences in Circulating Inflammatory Mediator 
Profiles after Severe Injury. J Am Coll Surg. 2019;228(2):148-60 e7. 
  







Figure 1. Experimental Group mapping leading to the SS and ST groups. Nineteen patients were 
excluded from the original 100 enrollees. Note that 9/48 (18.8%) of patients with 24 hr SHVL < 
100 were SS, and 10/33 (30.3%) with 24 hr SHVL > 100 were ST by the screening criteria.  
Figure 2. Linear regression shows significant correspondence (R
2
 = 0.49) between organ
dysfunction (aMODSD2-D5) and cumulative hypoperfusion (24hr SHVL) in 81 multiply injured 
patients. Two outlier sub-cohorts were identified that had higher magnitude organ dysfunction 
with lower 24hr SHVL (Shock Sensitive (SS) black dashed box; (aMODSD2-D5 > 4; 24hr SHVL 
< 100) or lower magnitude organ dysfunction and higher 24hr SHVL (Shock Tolerant (ST) red 
dashed box; aMODSD2-D5 < 4; 24hr SHVL > 100). 
Figure 3. Individual daily MODS scores for SS (black lines) and ST (red lines) groups 
demonstrate divergence in organ dysfunction trajectories nearly uniformly occurred between 
days 2 and 3 after injury, with resolution of organ dysfunction in ST patients. (* denotes 
significant difference with p < 0.05 between SS and ST groups) 
Figure 4. DyNA plots at each time interval for SS and ST patients demonstrate distinguishing 
features in mediator orchestration and clustering. Individual cytokines are denoted by the red and 
yellow nodes on the periphery of each circle (an enlarged nodal map detailing each mediator is 
available in Supplemental Figure 2, http://links.lww.com/TA/B830). Two-way arrows between 
cytokine nodes denote they are connected within that time interval. Two clusters of coordinated 






mediators were consistently identified including Cluster One (black dashed boxes) of eleven 
cytokines including IL-10, IL-17A, IL-1RA, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IP-10 and MCP-
1, and six cytokines in Cluster Two (red dashed boxes) that included IL-9, IL-21, IL-22, IL-23, 
IL-33 and IL-17E/25. The most notable features include early robust coordination of Cluster 
Two in ST patients in contrast to delayed coordination of Cluster Two in SS patients, high-
magnitude orchestration in Cluster One in the 8-24 hr interval in SS patients, and complete 
dissolution of immunologic coordination in ST patients by the 48-72 hr interval. ST patients 
maintained robust coordination of Cluster Two for the first 48 hr after injury. Overall 
connectivity graphs demonstrate delayed connectivity in SS patients in the initial 0-8 hr interval 
compared to ST patients.  
 
Supplemental Figure 1. Box and Whisker plots of all 20 mediators at all time points 
demonstrated no distinguishing features between ST and SS patients. IL-5 demonstrated the 
greatest magnitude difference between TS and TT patients but the differences were not 
significant. SS patients had significantly higher concentrations of HMGB1.  
 
Supplemental Figure 2. Individual cytokines in the DyNA circles are detailed.  
 
  











































(SS vs ST) 
Demographics, ISS, MVC 
Age in years, Mean (SD)§ 36.6 (11.4) 33.7 (12.5) 36.6 (11.8) .61 
Gender, Male/Female† 60/21 6/3 7/3 .88 
ISS, Mean (SD)§ 31.2 (14.1) 32.0 (13.2) 29.6 (8.5) .65 
MVC, Yes/No† 49/32 6/3 7/3 .88 
Comorbidities‡ .17 
Smoking 3 4 
Alcohol Abuse 1 1 
Diabetes 0 1 
COPD 1 1 
Cardiac Disease 0 0 
Liver Disease 0 0 
Kidney Disease 0 0 
Injury profiles‡ .92 
H/N 15 16 
Chest 33 20 
Abdomen 4 18 
Pelvis Retro 6 7 
Spine 14 2 
Extremity 10 22 
TBI: 4 4 
TBI Initial GCS, Mean (SD)§ 12.5 (3.5) 12.4 (3.7) .95 
GCS 15, Yes/No† 5/4 6/4 .84 
GCS ≤ 8, Yes/No† 2/7 2/8 .91 
TBI Final GCS, Mean (SD)§ 15.0 (0) 15.0 (0) >.99 
Surgical interventions‡ .70 
H/N 1 0 
Chest 3 1 
Abdomen 0 3 
Pelvis/Retro 2 0 
Spine 4 0 
Lower extremity 5 10 
Upper extremity 2 7 
SS, shock sensitive; ST, shock tolerant; n, number of patients; SD, standard deviation; ISS, 
injury severity score; MVC, motor vehicle crash; H/N, head and neck; TBI, traumatic brain 
injury; GCS, the Glasgow Coma Scale. § Student’s t-test; † Chi-square test; ‡ ANOVA test. 






Table 2.  Four methods intervals including Support Vector Machine (SVM) learning using Linear and Radial Based 
Functions, Random Forest Modeling and Decision Tree Analysis were used for discriminant analyses.   Random Forest 
modeling and Decision Tree analyses using mediator difference values in the 0 – 8 hr interval, depicted below (s.d. in 
parentheses) numerically provided the greatest distinguishing differences between SS and ST patients.  Subsequently, 
Elastic Net Linear Regression modeling was used to sequentially build discriminating rosters of mediators.  Once five 
cytokines including IL-1RA, MCP-1, IL-23, sIL-2RA, MIG were enrolled in the model, statistically significant 
discrimination was identified between SS and ST patients (p = 0.021) but predictive power was modest (R
2
 = 0.191).  
























IL-10, IL-1RA, IL-6, IP-10, MCP-1, IL-22, IL-










Il-10, IL-1RA, Il-6, IP-10, MCP-1, IL-22, IL-23, 







































































































SS, shock sensitive; ST, shock tolerant; SVM, support vector machine; RBF, radial basis function; SD, standard deviation; 
IL, interleukin; IL-1RA, the interleukin 1 receptor antagonist; IP-10, interferon gamma-induced protein 10; MCP-1, 
monocyte chemoattractant protein-1; sIL-2RA, soluble interleukin-2 receptor alpha; MIG, the monokine induced by 
interferon-gamma; HMGB1, high mobility group box 1. 
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